Yunhee Kang

Yunhee Kang

Auto-generated profile, based on publicly available information

Yunhee Kang

Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2021 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
YKYunhee Kang
Yunhee Kang
YZYing Zhou
Ying Zhou
YLYujing Li
Yujing Li
YHYanfei Han
Yanfei Han
JXJie Xu
Jie Xu
ZWZhexing Wen
Zhexing Wen

23 November 2022 in Science Advances
Verified
Journal Article
Open access
QLQiong Liu
Qiong Liu
KZKailin Zhang
Kailin Zhang
YKYunhee Kang
Yunhee Kang
YLYangping Li
Yangping Li
PDPenghui Deng
Penghui Deng
YPYongcheng Pan
Yongcheng Pan
GGC repeat expansions within NOTCH2NLC have been identified as the genetic cause of neuronal intranuclear inclusion disease (NIID). To understand the molecular pathogenesis of NIID, here, we established both a transgenic mouse model and a human neural progenitor cells (hNPCs) model. Expression of the NOTCH2NLC with expanded GGC repeats produced widespread intranuclear and perinuclear polyglycine (polyG), polyalanine (polyA), and polyarginine (polyR) inclusions, leading to behavioral deficits and severe neurodegeneration, which faithfully mimicked the clinical and pathological features associated with NIID. Furthermore, conserved alternative splicing events were identified between the NIID mouse and hNPC models, among which was the enrichment of the binding motifs of hnRNPM, an RNA binding protein known as alternative splicing regulator. Expanded NOTCH2NLC-polyG and NOTCH2NLC-polyA could interact with and sequester hnRNPM, while overexpression of hnRNPM could ameliorate the cellular toxicity. These results together suggested that dysfunction of hnRNPM could play an important role in the molecular pathogenesis of NIID.

27 February 2023 in Cells
Verified
Journal Article
Open access
PDF file
GCGiulia Cencelli
Giulia Cencelli
LPLaura Pacini
Laura Pacini
ALAnastasia De Luca
Anastasia De Luca
IMIlenia Messia
Ilenia Messia
AGAntonietta Gentile
Antonietta Gentile
CBClaudia Bagni
Claudia Bagni
Fragile X syndrome (FXS) is the most common form of monogenic intellectual disability and autism, caused by the absence of the functional fragile X messenger ribonucleoprotein 1 (FMRP). FXS features include increased and dysregulated protein synthesis, observed in both murine and human cells. Altered processing of the amyloid precursor protein (APP), consisting of an excess of soluble APPα (sAPPα), may contribute to this molecular phenotype in mice and human fibroblasts. Here we show an age-dependent dysregulation of APP processing in fibroblasts from FXS individuals, human neural precursor cells derived from induced pluripotent stem cells (iPSCs), and forebrain organoids. Moreover, FXS fibroblasts treated with a cell-permeable peptide that decreases the generation of sAPPα show restored levels of protein synthesis. Our findings suggest the possibility of using cell-based permeable peptides as a future therapeutic approach for FXS during a defined developmental window.

1 January 2006 in Neuroscience Letters
Verified
Journal Article
Closed access
WSWoong Sun
Woong Sun
YKYunhee Kang
Yunhee Kang
IKIl Hwan Kim
Il Hwan Kim
EKEun Hae Kim
Eun Hae Kim
IRIm Joo Rhyu
Im Joo Rhyu
HKHyun Kim
Hyun Kim